LC
NVRO

Lindbrook Capital’s NEVRO CORP. NVRO Stock Holding History

Lindbrook Capital’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-658
Closed -$5.54K – 2925
2024
Q2 		$5.54K Buy
658
+632
+2,431% +$6.74K ﹤0.01% 1949
2024
Q1 		$375 Sell
26
-44
-63% -$727 ﹤0.01% 2547
2023
Q4 		$1.51K Sell
70
-150
-68% -$2.68K ﹤0.01% 2363
2023
Q3 		$4.23K Buy
+220
New +$4.69K ﹤0.01% 1832
2023
Q2 		– Sell
-250
Closed -$9.04K – 2870
2023
Q1 		$9.04K Buy
250
+235
+1,567% +$8.25K ﹤0.01% 1508
2022
Q4 		$594 Sell
15
-279
-95% -$11.6K ﹤0.01% 2559
2022
Q3 		$14K Buy
294
+250
+568% +$11.6K ﹤0.01% 1188
2022
Q2 		$2K Buy
44
+9
+26% +$495 ﹤0.01% 2086
2022
Q1 		$3K Sell
35
-28
-44% -$2.02K ﹤0.01% 1901
2021
Q4 		$5K Buy
63
+55
+688% +$5.51K ﹤0.01% 1538
2021
Q3 		$1K Sell
8
-3
-27% -$393 ﹤0.01% 1808
2021
Q2 		$2K Hold
11
– – ﹤0.01% 1670
2021
Q1 		$2K Buy
+11
New +$1.79K ﹤0.01% 1628

Other funds holding NVRO

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Lindbrook Capital's NVRO Position: Q3 2024 in Review

Lindbrook Capital sold out of NEVRO CORP. (NVRO) in Q3 2024, closing a stake of 658 shares — an estimated $5.54K sold.

Lindbrook Capital first reported a position in NVRO in Q1 2021 and held it in 13 quarters. The position peaked at $14K in Q3 2022. 131 funds tracked by Wall St. Rank hold NVRO as of Q3 2024.

  • Lindbrook Capital reported no remaining NEVRO CORP. position as of Q3 2024 after selling out during the quarter.
  • Lindbrook Capital sold 658 NEVRO CORP. shares in Q3 2024, an estimated $5.54K.
  • Lindbrook Capital first reported a position in NEVRO CORP. in Q1 2021 and held it in 13 quarters.
  • Lindbrook Capital's NEVRO CORP. position peaked at $14K in Q3 2022.
  • 131 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2024.

Based on Lindbrook Capital's 13F filing for Q3 2024, filed 1 Nov 2024.